Muscle News and Research

RSS

Omeros announces financial results for second quarter of 2013

Omeros Corporation, a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the second quarter of 2013.

12 Aug 2013

Research: Chronic cocaine use may reduce body's ability to store fat

Chronic cocaine use may reduce the body's ability to store fat, new research from the University of Cambridge suggests. The scientists found that cocaine use may cause profound metabolic changes which can result in dramatic weight gain during recovery, a distressing phenomenon that can lead to relapse.

12 Aug 2013

Gene combination therapy repairs and prevents future damage of muscles caused by DMD

New research on two promising gene therapies suggests that combining them into one treatment not only repairs muscle damage caused by Duchenne muscular dystrophy, but also prevents future injury from the muscle-wasting disease.

12 Aug 2013

Study: 3 enzymes required for building sugar superstructure involved in muscular dystrophies

For many inherited diseases, such as cystic fibrosis or Huntington disease, the disease-causing genetic mutation damages or removes a protein that has an essential role in the body. This protein defect is the root cause of the disease symptoms.

9 Aug 2013

Penn State researchers find that protein changes can control gene functions

A Penn State-led research team has found that changes to proteins called histones, which are associated with DNA, can control whether or not a gene is allowed to function. The changes may be important in maintaining the genes' "expression potential" so that future cells behave as their parent cells did.

8 Aug 2013

Eteplirsen offers great hope to patients with Duchenne muscular dystrophy

Results from a clinical trial of eteplirsen, a drug designed to treat Duchenne muscular dystrophy, suggest that the therapy allows participants to walk farther than people treated with placebo and dramatically increases production of a protein vital to muscle growth and health.

8 Aug 2013

Researchers identify mechanism responsible for loss of tumor-suppressor gene in soft-tissue sarcomas

Researchers have discovered a novel mechanism responsible for the loss of a critical tumor-suppressor gene in rhabdomyosarcoma and other soft-tissue sarcomas, rare cancers that strike mainly children and often respond poorly to treatment. Their cause is largely unknown.

8 Aug 2013

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists at The Scripps Research Institute have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex. The largest and most recently evolved region of the brain, the neocortex is particularly well developed in humans and is responsible for sensory processing, long-term memory, reasoning, complex muscle actions, consciousness and other functions.

8 Aug 2013

Scientists identify important molecular signal that guides development of brain

Scientists at The Scripps Research Institute (TSRI) have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex.

8 Aug 2013

Johns Hopkins University receives $5.8M grant to research on causes of frailty in older adults

The federal government has awarded investigators at The Johns Hopkins University's schools of medicine and public health a multimillion-dollar, five-year grant to continue research designed to identify the causes of frailty in older adults, and speed the development of interventions to slow or stop it.

7 Aug 2013

Genetic variations in genes could put patients at risk for statin-associated muscle injury: Study

Statins, a class of drugs used to lower cholesterol, are among the best selling drugs in North America and around the world. However, statin myopathy, which results in muscle pain and weakness, is a common side effect affecting up to 10 percent of statin users. A recent study led by Dr. Richard Kim of the Lawson Health Research Institute, in collaboration with Dr. Robert Hegele of Robarts Research Institute, and researchers from Vanderbilt University, found that commonly occurring genetic variations in a person's genes could put them at risk for statin-associated muscle injury.

7 Aug 2013

Meridian Health earns Chest Pain Center Accreditation

Meridian Health, a leading New Jersey health care system, has recently earned the highest designated Chest Pain Center Accreditation by the Society of Cardiovascular Patient Care, a global not-for-profit organization committed to leading the fight to eliminate heart disease as the number one cause of death worldwide.

6 Aug 2013

Discovery brings scientists one step closer to understanding challenges linked to mercury cleanup

More forms of mercury can be converted to deadly methylmercury than previously thought, according to a study published Sunday in Nature Geoscience. The discovery provides scientists with another piece of the mercury puzzle, bringing them one step closer to understanding the challenges associated with mercury cleanup.

6 Aug 2013

Study observes that long-term use of antihypertensive drugs associated with breast cancer risk

Older women who take certain types of medication to combat high blood pressure may be putting themselves at greater risk for developing breast cancer, according to a new study by a team of Fred Hutchinson Cancer Research Center scientists led by Christopher Li, M.D., Ph.D.

6 Aug 2013

NIH-funded study of aquaporin proteins could hold clues to cataract

Researchers have achieved dynamic, atomic-scale views of a protein needed to maintain the transparency of the lens in the human eye. The work, funded in part by the National Institutes of Health, could lead to new insights and drugs for treating cataract and a variety of other health conditions.

6 Aug 2013

Study opens door to possible treatments for variety of mitochondrial diseases

By borrowing a tool from bacteria that infect plants, scientists have developed a new approach to eliminate mutated DNA inside mitochondria-the energy factories within cells. Doctors might someday use the approach to treat a variety of mitochondrial diseases, including the degenerative eye disease Leber hereditary optic neuropathy. The research, published online today in Nature Medicine, was funded by the National Eye Institute, a part of the National Institutes of Health.

5 Aug 2013

Muscle News and Research

Omeros announces financial results for second quarter of 2013

Research: Chronic cocaine use may reduce body's ability to store fat

Gene combination therapy repairs and prevents future damage of muscles caused by DMD

Study: 3 enzymes required for building sugar superstructure involved in muscular dystrophies

Penn State researchers find that protein changes can control gene functions

Eteplirsen offers great hope to patients with Duchenne muscular dystrophy

Researchers identify mechanism responsible for loss of tumor-suppressor gene in soft-tissue sarcomas

TSRI scientists decode important molecular signal that guides development of neocortex

Scientists identify important molecular signal that guides development of brain

Johns Hopkins University receives $5.8M grant to research on causes of frailty in older adults

Genetic variations in genes could put patients at risk for statin-associated muscle injury: Study

Meridian Health earns Chest Pain Center Accreditation

Discovery brings scientists one step closer to understanding challenges linked to mercury cleanup

Study observes that long-term use of antihypertensive drugs associated with breast cancer risk

NIH-funded study of aquaporin proteins could hold clues to cataract

Study opens door to possible treatments for variety of mitochondrial diseases

Life Care’s thoughts on neck pain from cervical herniated disc

Nubreed Nutrition teams up with legendary bodybuilder Lee Priest

Trace substance in sugar improves muscle regeneration in mouse model with muscular dystrophy

Research identifies important mechanism behind bladder cancer

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News